GlassScriptPhysician profile
John A Facchin
NPI 1659336055
$3,004.35
in general payments reported to CMS, 2019-2025
11 companies · $296 in 2025
The $296 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $437 · 2020: $413 · 2021: $272 · 2022: $850 · 2023: $455 · 2024: $282 · 2025: $296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,032.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,032.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $945.78 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $571.20 | 2019-2025 | Total30, Precision7 |
| Coopervision INC. | $374.59 | 2019-2025 | Clariti Contact Lens, Myday Contact Lens |
| Bausch & Lomb Americas INC. | $211.51 | 2022-2025 | Infuse, Biotrue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $158.78 | 2019-2021 | |
| Biotissue Holdings INC. | $144.72 | 2022 | |
| Glaukos Corporation | $144.22 | 2022 | |
| Sun Pharmaceutical Industries INC. | $137.78 | 2023-2024 | Cequa |
| Visioneering Technologies, INC. | $128.09 | 2023 | |
| Rxsight INC | $124.43 | 2023 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Allergan, INC. | $63.25 | 2021-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Facchin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.